Cannabis : Neuropsychiatry and Its Effects on Brain and Behavior
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent us...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (204 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545146504498 |
---|---|
ctrlnum |
(CKB)5400000000040759 (oapen)https://directory.doabooks.org/handle/20.500.12854/68363 (EXLCZ)995400000000040759 |
collection |
bib_alma |
record_format |
marc |
spelling |
Colizzi, Marco edt Cannabis Neuropsychiatry and Its Effects on Brain and Behavior Cannabis Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (204 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles. English Medicine bicssc Neurosciences bicssc delta-9-tetrahydrocannabinol placebo cannabis-associated psychosis schizophrenia BDNF CB1 CB2 episodic memory exercise African American black older adult marijuana use cannabis use disorder cue reactivity craving inhibitory control frontal alpha asymmetry EEG cannabinoids cannabis use psychotic disorder genetics age of onset clinical high risk cannabis memory functional magnetic resonance imaging THC systematic review gyrification surface area cortical surface structure aerobic fitness gender endocannabinoid system executive functions problematic cannabis use triple network EEG functional connectivity eLORETA resting state Delta-9-tetrahydrocannabinol dronabinol marijuana randomized controlled trial opioids traumatic injury alcohol adolescents fMRI interoception negative reinforcement migraine: chronic pain triptans disability 3-03943-995-2 3-03943-996-0 Bhattacharyya, Sagnik edt Colizzi, Marco oth Bhattacharyya, Sagnik oth |
language |
English |
format |
eBook |
author2 |
Bhattacharyya, Sagnik Colizzi, Marco Bhattacharyya, Sagnik |
author_facet |
Bhattacharyya, Sagnik Colizzi, Marco Bhattacharyya, Sagnik |
author2_variant |
m c mc s b sb |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
spellingShingle |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
title_sub |
Neuropsychiatry and Its Effects on Brain and Behavior |
title_full |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
title_fullStr |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
title_full_unstemmed |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
title_auth |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
title_alt |
Cannabis |
title_new |
Cannabis |
title_sort |
cannabis neuropsychiatry and its effects on brain and behavior |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2021 |
physical |
1 electronic resource (204 p.) |
isbn |
3-03943-995-2 3-03943-996-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT colizzimarco cannabisneuropsychiatryanditseffectsonbrainandbehavior AT bhattacharyyasagnik cannabisneuropsychiatryanditseffectsonbrainandbehavior AT colizzimarco cannabis AT bhattacharyyasagnik cannabis |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040759 (oapen)https://directory.doabooks.org/handle/20.500.12854/68363 (EXLCZ)995400000000040759 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Cannabis Neuropsychiatry and Its Effects on Brain and Behavior |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796651990396174336 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04152nam-a2201009z--4500</leader><controlfield tag="001">993545146504498</controlfield><controlfield tag="005">20231214133253.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040759</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68363</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040759</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Colizzi, Marco</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cannabis</subfield><subfield code="b">Neuropsychiatry and Its Effects on Brain and Behavior</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Cannabis </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (204 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurosciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">delta-9-tetrahydrocannabinol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">placebo</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabis-associated psychosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">schizophrenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BDNF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CB1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">episodic memory</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exercise</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">African American</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">black</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">older adult</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marijuana use</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabis use disorder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cue reactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">craving</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inhibitory control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">frontal alpha asymmetry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EEG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabinoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabis use</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">psychotic disorder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">age of onset</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical high risk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cannabis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">memory</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">functional magnetic resonance imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">THC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systematic review</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gyrification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surface area</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cortical surface structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aerobic fitness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gender</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endocannabinoid system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">executive functions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">problematic cannabis use</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triple network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EEG functional connectivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eLORETA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resting state</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Delta-9-tetrahydrocannabinol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dronabinol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marijuana</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">randomized controlled trial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">opioids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">traumatic injury</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alcohol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adolescents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fMRI</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interoception</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">negative reinforcement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">migraine: chronic pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triptans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disability</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-995-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-996-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhattacharyya, Sagnik</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Colizzi, Marco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhattacharyya, Sagnik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:47 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337916470004498&Force_direct=true</subfield><subfield code="Z">5337916470004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337916470004498</subfield></datafield></record></collection> |